PT998493E - Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos - Google Patents
Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticosInfo
- Publication number
- PT998493E PT998493E PT98935164T PT98935164T PT998493E PT 998493 E PT998493 E PT 998493E PT 98935164 T PT98935164 T PT 98935164T PT 98935164 T PT98935164 T PT 98935164T PT 998493 E PT998493 E PT 998493E
- Authority
- PT
- Portugal
- Prior art keywords
- shigella
- toxin
- epithops
- vaccines
- diagnostics
- Prior art date
Links
- 239000003053 toxin Substances 0.000 title abstract 3
- 231100000765 toxin Toxicity 0.000 title abstract 3
- 241000607768 Shigella Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 241001646719 Escherichia coli O157:H7 Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/25—Shigella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715177A GB9715177D0 (en) | 1997-07-21 | 1997-07-21 | Medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
PT998493E true PT998493E (pt) | 2005-03-31 |
Family
ID=10816080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98935164T PT998493E (pt) | 1997-07-21 | 1998-07-17 | Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos |
Country Status (11)
Country | Link |
---|---|
US (1) | US6410024B1 (pt) |
EP (1) | EP0998493B1 (pt) |
JP (1) | JP4397523B2 (pt) |
AT (1) | ATE283282T1 (pt) |
AU (1) | AU747197B2 (pt) |
CA (1) | CA2295940C (pt) |
DE (1) | DE69827800T2 (pt) |
ES (1) | ES2234132T3 (pt) |
GB (1) | GB9715177D0 (pt) |
PT (1) | PT998493E (pt) |
WO (1) | WO1999005169A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858211B1 (en) * | 1998-07-20 | 2005-02-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccines against Escherichia coli O157 infection |
EP1295916B1 (en) | 2000-06-07 | 2014-11-26 | Seiko Epson Corporation | Ink-jet recording ink, ink-jet recording ink set, recording method, print, and ink-jet recording apparatus |
WO2009088403A2 (en) * | 2007-10-08 | 2009-07-16 | Rutgers, The State University | Nontoxic shiga-like toxin mutant compositions and methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955293A (en) * | 1989-10-17 | 1999-09-21 | New England Medical Center Hospitals, Inc. | Assays for shiga toxin and shiga-like toxins |
US5552144A (en) * | 1992-01-22 | 1996-09-03 | Microcarb, Inc. | Immunogenic shiga-like toxin II variant mutants |
WO1993018784A1 (en) * | 1992-03-26 | 1993-09-30 | Microcarb, Inc. | Monospecific polyclonal antibodies to shiga-like toxins |
US5719064A (en) * | 1992-08-31 | 1998-02-17 | Oklahoma Medical Research Foundation | Peptide diagnostics and therapeutics for spondyloarthropathies |
US5679564A (en) * | 1994-10-05 | 1997-10-21 | Antex Biologics, Inc. | Methods for producing enhanced antigenic campylobacter bacteria and vaccines |
WO1996030043A1 (en) | 1995-03-24 | 1996-10-03 | Ophidian Pharmaceuticals | Treatment for verotoxin-producing escherichia coli |
AU4184597A (en) | 1996-09-10 | 1998-04-02 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
-
1997
- 1997-07-21 GB GB9715177A patent/GB9715177D0/en active Pending
-
1998
- 1998-07-17 WO PCT/GB1998/002156 patent/WO1999005169A1/en active IP Right Grant
- 1998-07-17 ES ES98935164T patent/ES2234132T3/es not_active Expired - Lifetime
- 1998-07-17 US US09/463,129 patent/US6410024B1/en not_active Expired - Fee Related
- 1998-07-17 JP JP2000504162A patent/JP4397523B2/ja not_active Expired - Fee Related
- 1998-07-17 AU AU84520/98A patent/AU747197B2/en not_active Ceased
- 1998-07-17 DE DE69827800T patent/DE69827800T2/de not_active Expired - Lifetime
- 1998-07-17 CA CA2295940A patent/CA2295940C/en not_active Expired - Fee Related
- 1998-07-17 EP EP98935164A patent/EP0998493B1/en not_active Expired - Lifetime
- 1998-07-17 PT PT98935164T patent/PT998493E/pt unknown
- 1998-07-17 AT AT98935164T patent/ATE283282T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU8452098A (en) | 1999-02-16 |
EP0998493A1 (en) | 2000-05-10 |
JP2001510850A (ja) | 2001-08-07 |
AU747197B2 (en) | 2002-05-09 |
WO1999005169A1 (en) | 1999-02-04 |
CA2295940A1 (en) | 1999-02-04 |
ES2234132T3 (es) | 2005-06-16 |
CA2295940C (en) | 2010-06-15 |
US6410024B1 (en) | 2002-06-25 |
EP0998493B1 (en) | 2004-11-24 |
GB9715177D0 (en) | 1997-09-24 |
JP4397523B2 (ja) | 2010-01-13 |
DE69827800T2 (de) | 2005-11-24 |
DE69827800D1 (de) | 2004-12-30 |
ATE283282T1 (de) | 2004-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
DE69129302D1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
ES2293973T3 (es) | Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos. | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
DE69531679D1 (de) | Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper | |
ATE302411T1 (de) | Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens | |
TR200202799T3 (tr) | AB peptidini sekanslayan insanlaştırılmış antikorlar | |
NO973447L (no) | Monoklonale antistoffer som er spesifikke for forskjellige epitoper i human-gp 39, og fremgangsmåter for deres anvendelse i diagnose og terapi | |
DE69129460D1 (de) | Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK | |
ATE304371T1 (de) | Verwendung von staphylococcus enterotoxin homologe für krebs-therapie | |
ATE310088T1 (de) | Behandlung und nachweis von staphylokokkeninfektionen | |
PT628077E (pt) | Anticorpos humanizados direccionados contra o antigenio de a33 | |
DE60129278D1 (de) | Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen | |
EP1411962A4 (en) | MONOCLONAL ANTIBODY TREATMENT OF PANCREATIC CANCER | |
PT1042492E (pt) | Anticorpos monoclonais humanizados que protegem contra doença induzida pela toxina shiga | |
PT998493E (pt) | Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos | |
PT917471E (pt) | Tratamento e diagnostico de infeccoes por cocci gram-positivo | |
ATE208403T1 (de) | Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren | |
DK0513565T3 (da) | Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse | |
ATE209659T1 (de) | Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren | |
EP0450573A3 (en) | Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections |